Inventor
Yasunobu Tanaka
Inventor
Osaka, JP
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
C12NMicroorganisms or enzymes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
C07CAcyclic or carbocyclic compounds10%
C07HSugars9%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds3%
Y10TTechnical subjects covered by former us classification3%
A61LMethods or apparatus for sterilising materials or objects in general2%
PatentTitleYear
11,084,779Cationic lipids for therapeutic agent delivery formulations202110,961,181Cationic lipids for therapeutic agent delivery formulations202110,669,229Compounds for targeting drug delivery and enhancing siRNA activity202010,532,975Cationic lipids for therapeutic agent delivery formulations202010,196,637Retinoid-lipid drug carrier201910,195,145Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier201910,100,004Compounds for targeting drug delivery and enhancing siRNA activity201810,093,923Modulation of HSP47 expression201810,000,447Compounds for targeting drug delivery and enhancing siRNA activity20189,963,424Cationic lipids for therapeutic agent delivery formulations20189,456,984'Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier'20169,393,315'Compounds for targeting drug delivery and enhancing siRNA activity'20169,242,001'Cationic lipids for therapeutic agent delivery formulations'20169,206,424'Modulation of HSP47 expression'20159,011,903'Cationic lipids for therapeutic agent delivery formulations'20158,741,867'Retinoid-liposomes for treating fibrosis'20148,710,209'Modulation of HSP47 expression'20148,664,376'Retinoid-liposomes for enhancing modulation of HSP47 expression'20148,574,623'Therapeutic agent for pulmonary fibrosis'20138,334,042'Sandwich panel'20128,216,558'Polymer coating of cells'20127,700,541'Biodegradable cationic polymers'20107,674,452'Polymer coating of cells'20107,125,709'Culture device and method for eukaryotic cell transfection'2006Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2006–2021Patents assigned to NITTO DENKO CORP (22)· patent assignee history
2006–2012Based in San Diego, CA, US· patent location history
2012–2016Patents assigned to TANAKA YASUNOBU (7)· patent assignee history
2013Based in Ibaraki, JP· patent location history
2014–2016Patents assigned to NIITSU YOSHIRO (5)· patent assignee history
2014–2016Patents assigned to AHMADIAN MOHAMMAD (4)· patent assignee history
2014–2016Patents assigned to AKOPIAN VIOLETTA (4)· patent assignee history
2014–2021Based in Osaka, JP· patent location history
2014–2018Based in Sapporo, JP· patent location history
2021Based in Osaka-shi, JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NITTO DENKO CORP | 22 | 2006–2021 |
| TANAKA YASUNOBUself | 7 | 2012–2016 |
| NIITSU YOSHIRO | 5 | 2014–2016 |
| AHMADIAN MOHAMMAD | 4 | 2014–2016 |
| AKOPIAN VIOLETTA | 4 | 2014–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Osaka, JP | 14 | 2014–2021 |
| San Diego, California, US | 4 | 2006–2012 |
| Sapporo, JP | 3 | 2014–2018 |
| Osaka-shi, JP | 1 | 2021 |
| Ibaraki, JP | 1 | 2013 |